Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
Ying Wei, Sonia Erfani, David S. Schweer, Rafael de Gouvea et autres
Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide. Receptor tyrosine kinases (RTKs) have long been sought as therapeutic targets for EOC, as they are frequently hyperactivated in primary tumors and drive disease relapse, progression, …
cn, us, ca (code pays fourni par la source)
20 citations
Molecular Therapy — Oncolytics